Get the Stockscreener App
5.75
2.06%
0.17
Atossa Therapeutics Inc Stock (ATOS) Forecast
The Atossa Therapeutics Inc (ATOS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.2896, representing a -77.57% decrease from the current price of $5.75. The highest analyst price target is $1.6038, and the lowest is $0.9754.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATOS Price Target
Average 4.5786
(-20.37% Downside)
Is Atossa Therapeutics Inc (ATOS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 52.08 | Neutral |
| STOCH(9,6) | 29.89 | Neutral |
| STOCHRSI(14) | 27.63 | Neutral |
| MACD(12,26) | 0.079 | Sell |
| ADX(14) | 23.92 | Neutral |
| William %R | -62.61 | Neutral |
| CCI(14) | 1.427 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.574
Buy
|
5.5566
Buy
|
| MA20 |
5.521
Buy
|
5.4978
Buy
|
| MA50 |
5.1563
Buy
|
5.6728
Sell
|
| MA100 |
6.7894
Sell
|
6.826
Sell
|
| MA200 |
9.7304
Sell
|
8.5585
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, ATOS could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ATOS, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 52.08 indicates that ATOS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.89 indicates that ATOS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 27.63 indicates that ATOS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.92 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 1.427 indicates that ATOS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ATOS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Atossa Therapeutics Inc financial reports and earnings history, Atossa Therapeutics Inc (ATOS) stock could reach $0.6825 by 2030, $1.5007 by 2040 and $2.9864 by 2050. See the projected annual prices until 2050 of the Atossa Therapeutics Inc stock below:
- Atossa Therapeutics Inc (ATOS) is expected to reach an average price of $0.5831 in 2035, with a high prediction of $0.7078 and a low estimate of $0.7028. This indicates an $-89.86% rise from the last recorded price of $5.75.
- Atossa Therapeutics Inc (ATOS) stock is projected to chart a bullish course in 2040, with an average price target of $1.5815, representing an $-72.50% surge from its current level. The forecast ranges from a conservative $1.5355 to a sky-high $1.5007.
- Our analysts predict Atossa Therapeutics Inc (ATOS) to jump -58.98% by 2045, soaring from $2.3045 to an average price of $2.3585, potentially reaching $2.2953. While $2.3045 is the low estimate, the potential upside is significant.
- Atossa Therapeutics Inc (ATOS) stock is expected to climb by 2050, reaching an average of $2.6627, a $-53.69% jump from its current level. However, a wide range of estimates exists, with high and low targets of $2.9864 and $3.0385, respectively, highlighting the market's uncertainty.
Atossa Therapeutics Inc Stock (ATOS) Year by Year Forecast
Atossa Therapeutics Inc Stock (ATOS) Price Forecast for 2026
The predicted value for Atossa Therapeutics Inc (ATOS) in 2026 is set at an average of $4.453. Estimates vary from a peak of $8.8859 to a trough of $0.02, indicating an -22.56% surge from the present price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2026 | $1.0885 | $0.9754 | $1.6038 | -81.07% |
| July, 2026 | $1.9764 | $0.5517 | $2.1564 | -65.63% |
| August, 2026 | $3.3928 | $1.9896 | $5.9028 | -41.00% |
| September, 2026 | $4.4107 | $3.4343 | $8.8859 | -23.29% |
| October, 2026 | $2.4768 | $1.847 | $6.2422 | -56.93% |
| November, 2026 | $2.9033 | $2.1401 | $2.9617 | -49.51% |
| December, 2026 | $2.3812 | $2.2212 | $3.415 | -58.59% |
Atossa Therapeutics Inc Stock (ATOS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Atossa Therapeutics Inc (ATOS) is $1.2261, with a high forecast of $2.4444 and a low forecast of $0.00794. This indicates an -78.68% decrease from the last price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.8975 | $1.8075 | $2.4444 | -67.00% |
| February, 2027 | $1.4738 | $1.3938 | $2.0287 | -74.37% |
| March, 2027 | $1.1017 | $0.9517 | $1.5754 | -80.84% |
| April, 2027 | $0.5981 | $0.5181 | $1.0633 | -89.60% |
| May, 2027 | $0.3944 | $0.2712 | $0.6096 | -93.14% |
| June, 2027 | $0.3623 | $0.1791 | $0.646 | -93.70% |
| July, 2027 | $0.4086 | $0.2455 | $0.777 | -92.89% |
| August, 2027 | $0.1849 | $0.1649 | $0.4502 | -96.78% |
| September, 2027 | $0.1308 | $0.00794 | $0.2865 | -97.72% |
| October, 2027 | $0.2192 | $0.083 | $0.5376 | -96.19% |
| November, 2027 | $0.2655 | $0.166 | $0.4223 | -95.38% |
| December, 2027 | $0.2734 | $0.0803 | $0.2834 | -95.25% |
Atossa Therapeutics Inc Stock (ATOS) Price Forecast for 2028
In 2028, Atossa Therapeutics Inc (ATOS) is projected to reach an average price of $0.3329, with a high projection of $0.6656 and a low estimate of $0.000331. This indicates an -94.21% fall from the last price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1125 | $0.0947 | $0.345 | -98.04% |
| February, 2028 | $0.0393 | $0.00323 | $0.2013 | -99.32% |
| March, 2028 | $0.1991 | $0.00265 | $0.2723 | -96.54% |
| April, 2028 | $0.0402 | $0.000331 | $0.2355 | -99.30% |
| May, 2028 | $0.196 | $0.0266 | $0.1618 | -96.59% |
| June, 2028 | $0.0411 | $0.0145 | $0.2345 | -99.29% |
| July, 2028 | $0.0332 | $0.0176 | $0.1077 | -99.42% |
| August, 2028 | $0.0765 | $0.0245 | $0.0812 | -98.67% |
| September, 2028 | $0.0206 | $0.0525 | $0.0597 | -99.64% |
| October, 2028 | $0.0527 | $0.0518 | $0.0387 | -99.08% |
| November, 2028 | $0.2101 | $0.0137 | $0.2861 | -96.35% |
| December, 2028 | $0.5356 | $0.1224 | $0.6656 | -90.69% |
Atossa Therapeutics Inc Stock (ATOS) Price Forecast for 2029
The 2029 price forecast for Atossa Therapeutics Inc Stock (ATOS) is $0.8373 on average, with a high prediction of $1.6583 and a low estimate of $0.0163. This represents an -85.44% decrease from the previous price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3835 | $0.3019 | $0.6587 | -93.33% |
| February, 2029 | $0.1408 | $0.1248 | $0.425 | -97.55% |
| March, 2029 | $0.0866 | $0.0245 | $0.236 | -98.49% |
| April, 2029 | $0.0375 | $0.0191 | $0.1387 | -99.35% |
| May, 2029 | $0.0547 | $0.0412 | $0.0873 | -99.05% |
| June, 2029 | $0.0765 | $0.0163 | $0.1481 | -98.67% |
| July, 2029 | $0.203 | $0.0198 | $0.423 | -96.47% |
| August, 2029 | $0.1849 | $0.1037 | $0.3096 | -96.78% |
| September, 2029 | $0.3172 | $0.1619 | $0.3872 | -94.48% |
| October, 2029 | $1.0151 | $0.2988 | $1.0751 | -82.35% |
| November, 2029 | $0.7214 | $0.5914 | $1.6583 | -87.45% |
| December, 2029 | $0.4231 | $0.3662 | $0.948 | -92.64% |
Atossa Therapeutics Inc Stock (ATOS) Price Forecast for 2030
Atossa Therapeutics Inc Stock (ATOS) is expected to reach an average price of $0.583 in 2030, with a high forecast of $1.1096 and a low forecast of $0.0564. This signifies an -89.86% decrease from the last price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.063 | $0.0762 | $0.6825 | -98.90% |
| February, 2030 | $0.0379 | $0.0915 | $1.0583 | -99.34% |
| March, 2030 | $0.0173 | $0.0927 | $0.2273 | -99.70% |
| April, 2030 | $0.1801 | $0.0564 | $0.2936 | -96.87% |
| May, 2030 | $0.2093 | $0.1374 | $0.0963 | -96.36% |
| June, 2030 | $0.4114 | $0.4316 | $0.3016 | -92.84% |
| July, 2030 | $0.7358 | $0.5453 | $0.7059 | -87.20% |
| August, 2030 | $0.5632 | $0.7263 | $0.6824 | -90.21% |
| September, 2030 | $0.5312 | $0.5468 | $0.4344 | -90.76% |
| October, 2030 | $0.7247 | $0.6196 | $0.6147 | -87.40% |
| November, 2030 | $1.1521 | $0.7716 | $0.9051 | -79.96% |
| December, 2030 | $1.0394 | $0.9226 | $1.1096 | -81.92% |
0.78%
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):